STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

ENANTA PHARMACEUTICALS INC

Filed

December 3, 2025

Period of Report

December 1, 2025

Accession Number

0002064832-25-000046